泌尿系结石患者的代谢评估与复发预防:EAU指南更新
该综述为EAU泌尿系结石指南更新,基于1976年至2023年6月的文献检索,定义了结石复发高危患者,并按结石类型给出诊断与治疗流程及复发预防推荐。所有结石患者应尝试结石分析并接受一般预防指导;钙结石高危患者应行两次24小时尿液收集的全面代谢筛查并接受针对性治疗;代谢评估与随访被高度推荐以预防复发。
要点
- 所有泌尿系结石患者均应尝试结石分析,并接受一般复发预防指导。
- 钙结石且高复发/并发症风险患者应行两次24小时尿液收集的全面代谢筛查并接受针对性治疗。
- 尿酸、感染或胱氨酸结石患者属高复发风险,所有高复发风险患者应密切监测。
核心结论
- 高度推荐进行代谢性结石评估和患者随访以预防泌尿系结石复发。
研究设计与样本
- EAU泌尿系结石指南更新,由专业研究馆员对指南各章节进行文献检索,覆盖1976年至2023年6月的时间段。
主要发现
- 对每位泌尿系结石患者均应尝试进行结石分析。
- 应给予患者一般复发预防指导,包括充分液体和钙摄入,以及低钠和低蛋白摄入。
- 识别并纠正病因因素是预防泌尿系结石复发的基石。
- 可按结石成分获得诊断和治疗流程。
- 每位患者应接受基线代谢筛查,而钙结石且高复发和并发症风险的患者应接受两次24小时尿液收集的全面代谢筛查并接受针对性治疗。
关键数值与推荐
- 每位泌尿系结石患者均应尝试结石分析。
- 一般复发预防指导包括充分液体和钙摄入,以及低钠和低蛋白摄入。
- 每位患者应接受基线代谢筛查。
- 钙结石且高复发和并发症风险的患者应接受两次24小时尿液收集的全面代谢筛查并接受针对性治疗。
- 所有高复发风险患者应密切监测,尤其是长期不依从治疗者。
临床怎么用
- 对泌尿系结石患者应尝试结石分析并给予一般预防指导。
- 对钙结石高复发和并发症风险患者应行两次24小时尿液收集的全面代谢筛查并给予针对性治疗。
- 对尿酸、感染或胱氨酸结石患者应视为高复发风险并密切监测。
- 高度推荐代谢性结石评估和患者随访以预防复发。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: The aim of this review was to define patients who are at high risk of recurrence of urolithiasis, to delineate diagnostic and therapeutic algorithms for each type of stone, and to clarify general guidelines and recommendations for prevention of recurrence. METHODS: A professional research librarian carried out literature searches for all sections of the urolithiasis guidelines, covering the timeframe between 1976 and June 2023. KEY FINDINGS AND LIMITATIONS: For every patient with urolithiasis, an attempt should be made to analyse the stone. Patients should be given general instructions on how to prevent recurrence, including adequate fluid and calcium intake, and low consumption of sodium and protein. Identifying and correcting the causative factors is a cornerstone in preventing the recurrence of urolithiasis. Diagnostic and therapeutic algorithms by stone composition are available. Every patient should undergo baseline metabolic screening, while patients with calcium stones, who are at high risk of relapse and complications, should undergo extensive metabolic screening with two 24-h urine collections and should receive targeted therapy. Patients with uric acid, infection, or cystine stones are at high risk of relapse. All patients at high risk of recurrence should be closely monitored, especially those not complying with therapy in the long term. CONCLUSIONS AND CLINICAL IMPLICATIONS: Metabolic stone evaluation and patient follow-up are highly recommended to prevent urolithiasis recurrence.
引用
- Skolarikos A, Somani B, Neisius A, et al. Metabolic Evaluation and Recurrence Prevention for Urinary Stone Patients: An EAU Guidelines Update. Eur Urol. 2024. PMID: 39069389. doi:10.1016/j.eururo.2024.05.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。